LIVE Webinar 

Empowered and Prepared: 10 Key Questions for Your Next Allergist Visit

Join us November 20, 2025, at 1:00 p.m. ET

Food allergy care is evolving fast—from biologics and oral immunotherapy (OIT) to new epinephrine delivery options—and today's patients have more choices than ever before. But with more options comes the need for more personalized care. How do you know what’s right for you or your child?

Join us on Thursday, November 20, at 1:00 p.m. ET, for this practical and empowering session, in which leading allergist Dr. Wayne Shreffler will walk you through 10 key questions to ask at your next allergist visit. He will be joined by moderator Kelly Cleary, MD, FAAP, FARE’s Medical Director and Vice President of Health and Education. Whether you're wondering if you're a candidate for OIT, considering a biologic, or just trying to keep up with the latest tools and treatments, this session will arm you with the knowledge and confidence to make shared decisions with your doctor.

This session will provide the questions that get you the answers! 
Write your awesome label here.

Wayne Shreffler, MD, PhD

About the speaker
Wayne Shreffler MD PhD, is Chief of Pediatric Allergy & Immunology and Co-Director of the Food Allergy Center at Massachusetts General Hospital. He is also an Investigator at the Center for Immunology and Inflammatory Disease and the Food Allergy Science Initiative. Dr. Shreffler received his MD and PhD degrees from New York University and his Pediatrics training at the Albert Einstein College of Medicine. He completed his fellowship in Allergy & Immunology at the Mount Sinai School of Medicine in 2003. He is board certified in Pediatrics and Allergy/ Immunology and is a fellow of the American Academy of Allergy, Asthma and Immunology. Since coming to MGH in 2010, he has developed a highly integrated research and clinical program to better understand how adaptive immunity to dietary antigens is both naturally regulated and modulated by therapy in the context of food allergy. 
This webinar is sponsored by RAPT Therapeutics.